HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 28/1/51    most recent 09031936.06.00058505v1 Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yasuda, H. Articles by Sasaki, H. Search for Related Content PubMed PubMed Citation Articles by Yasuda, H. Articles by Sasaki, H.

Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells

¹ Dept of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, and ² Virus Research Centre, Clinical Research Division, Sendai National Hospital, Sendai, Japan.

CORRESPONDENCE: H. Yasuda, Dept of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, 1-Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. Fax: 81 227177186. E-mail: yasuda{at}geriat.med.tohoku.ac.jp

Keywords: Common cold, endosome, intercellular adhesion molecule, mucolytic drug, rhinovirus

Received: May 18, 2005
Accepted February 17, 2006

The aim of the study was to examine the effects of a mucolytic drug, carbocisteine, on rhinovirus (RV) infection in the airways.

Human tracheal epithelial cells were infected with a major-group RV, RV14.

RV14 infection increased virus titres and the cytokine content of supernatants. Carbocisteine reduced supernatant virus titres, the amount of RV14 RNA in cells, cell susceptibility to RV infection and supernatant cytokine concentrations, including interleukin (IL)-6 and IL-8, after RV14 infection. Carbocisteine reduced the expression of mRNA encoding intercellular adhesion molecule (ICAM)-1, the receptor for the major group of RVs. It also reduced the supernatant concentration of a soluble form of ICAM-1, the number and fluorescence intensity of acidic endosomes in the cells before RV infection, and nuclear factor-B activation by RV14. Carbocisteine also reduced the supernatant virus titres of the minor group RV, RV2, although carbocisteine did not reduce the expression of mRNA encoding a low density lipoprotein receptor, the receptor for RV2.

These results suggest that carbocisteine inhibits rhinovirus 2 infection by blocking rhinovirus RNA entry into the endosomes, and inhibits rhinovirus 14 infection by the same mechanism as well as by reducing intercellular adhesion molecule-1 levels. Carbocisteine may modulate airway inflammation by reducing the production of cytokines in rhinovirus infection.